Vicarious Surgical Inc (NYSE:RBOT – Get Free Report)’s share price traded up 1% during trading on Thursday . The stock traded as high as $6.10 and last traded at $5.86. 7,904 shares changed hands during mid-day trading, a decline of 71% from the average session volume of 26,929 shares. The stock had previously closed at $5.80.
Analyst Upgrades and Downgrades
RBOT has been the subject of several research analyst reports. Piper Sandler cut their target price on Vicarious Surgical from $30.00 to $12.00 and set a “neutral” rating for the company in a research report on Tuesday, August 13th. Morgan Stanley dropped their price target on Vicarious Surgical from $18.00 to $10.00 and set an “equal weight” rating for the company in a research note on Monday, July 15th.
Read Our Latest Research Report on Vicarious Surgical
Vicarious Surgical Stock Performance
Vicarious Surgical (NYSE:RBOT – Get Free Report) last announced its earnings results on Monday, August 12th. The company reported ($2.86) earnings per share for the quarter, beating the consensus estimate of ($2.98) by $0.12. On average, equities analysts forecast that Vicarious Surgical Inc will post -10.07 EPS for the current year.
About Vicarious Surgical
Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Read More
- Five stocks we like better than Vicarious Surgical
- Upcoming IPO Stock Lockup Period, Explained
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- Using the MarketBeat Dividend Tax Calculator
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- ETF Screener: Uses and Step-by-Step Guide
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.